{"@type": "dcat:Dataset", "accessLevel": "public", "bureauCode": ["009:25"], "contactPoint": {"@type": "vcard:Contact", "fn": "NIH/NCBI Data Team", "hasEmail": "mailto:info@ncbi.nlm.nih.gov"}, "description": "The infusion preparation for peripheral parenteral administration comprises an infusion (A) containing glucose with 80 to 200 g/L concentration, and an infusion (B) containing amino acid with 50 to 150 g/L concentration. The infusion (A) and the infusion (B) are separately put into a vessel that is divided with an openable partition means. The infusion (A) does not contain sulfite, has titratable acidity of 1 or less, contains vitamin B1 and is adjusted to pH 3 to 5. The infusion (B) is adjusted to pH 6.5 to 8. After mixing the both infusions, the mixture has pH 6 to 7.5 and titratable acidity of 5 to 10.", "distribution": [{"@type": "dcat:Distribution", "description": "Access the complete Patent AT-E399556-T1: [Translated] TRANSFUSION PREPARATION FOR PERIPHERAL INTRAVENOUS ADMINISTRATION AND METHOD FOR STABILIZING VITAMIN B1 on the official website.", "downloadURL": "https://pubchem.ncbi.nlm.nih.gov/patent/AT-E399556-T1", "mediaType": "text/html", "title": "Official Data Source"}], "identifier": "https://healthdata.gov/api/views/tazs-nku2", "issued": "2025-09-05", "keyword": ["chemistry", "innovation", "patent", "pubchem", "research"], "landingPage": "https://healthdata.gov/d/tazs-nku2", "modified": "2025-09-06", "programCode": ["009:066"], "publisher": {"@type": "org:Organization", "name": "National Center for Biotechnology Information (NCBI)"}, "theme": ["NIH"], "title": "Patent AT-E399556-T1: [Translated] TRANSFUSION PREPARATION FOR PERIPHERAL INTRAVENOUS ADMINISTRATION AND METHOD FOR STABILIZING VITAMIN B1"}